Merck to acquire Harpoon Therapeutics for USD 680 million Ruchika Sharma10 Jan 2024 4:31 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. have announced that the companies have...
Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline Ruchika Sharma6 Jan 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its...
Merck seeks GLP-1 drugs with benefits beyond weight loss, says CEO Ruchika Sharma5 Jan 2024 3:36 PM ISTRahway: Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.Newer...
Aurobindo Pharma arm bags USFDA nod for Posaconazole Injection Ruchika Sharma27 Dec 2023 2:48 PM ISTHyderabad: Aurobindo Pharma Limited has announced that its wholly-owned subsidiary company, Eugia Pharma Specialities Limited, has received...
Merck gets European Commission nod for two new indications for Keytruda in gastrointestinal cancers Ruchika Sharma22 Dec 2023 11:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the European Commission (EC) has approved two new indications...
USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults Ruchika Sharma21 Dec 2023 3:47 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
USFDA declines to approve Merck chronic cough drug Gefapixant Ruchika Sharma21 Dec 2023 11:30 AM ISTNew Jersey: The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday,...
Merck bags USFDA nod for Keytruda, Padcev combo for urothelial cancer Ruchika Sharma18 Dec 2023 1:45 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
USFDA gives tentative nod for Lupin diabetes drug Sitagliptin Ruchika Sharma16 Dec 2023 11:30 AM ISTSitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2...
Merck Welireg gets USFDA approval for kidney cancer Ruchika Sharma15 Dec 2023 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck Animal Health receives positive CVMP opinion for injectable formulation of Bravecto for dogs Ruchika Sharma12 Dec 2023 4:30 PM ISTBased on the CVMP's recommendation, the EC is expected to issue a decision for marketing authorization in the European Union during the first quarter...
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
